₹ 1124.2
Key Takeaways
Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Slightly undervalued vs peers
About
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides housing finance and other financing solutions, such as private equity, structured debt, senior secured debt, construction finance, and flexi lease rental discounting to...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITD.
Target Price
The average target price of PEL.NS is 1254 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
